The 2019-20 fiscal year was a strong one for the Indiana University Innovation and Commercialization Office, said Simran Trana, IU associate vice president of innovation and commercialization. “This was an unusual year, and not only because of the impact of the novel coronavirus,” Trana said. “IU researchers quickly pivoted their work to create new methods… Read more »
Technology Commercialization
These 64 IU researchers were named on issued patents in 2019-20
The Indiana University Innovation and Commercialization Office again reported a strong year in technology transfer activity. It received 157 patents from the U.S. Patent and Trademark Office and foreign patent organizations during the 2019-20 fiscal year. Sixty-four current IU researchers were named on the patents. They are: IU Bloomington Andrew Alexander Lane Baker Yves Brun… Read more »
Another example of IU expertise at innovation and commercialization
By Samantha Ginther, senior associate, IU Ventures Everyone at the Indiana University Innovation and Commercialization Office and IU Ventures congratulates drug discovery company MBX Biosciences for recently completing a $34.6 million Series A round of funding. This is the latest entrepreneurial good news for Indiana University researcher and Distinguished Professor Richard DiMarchi, IUPUI alumnus Kent… Read more »
Q&A with Nancy T. Chang, Ph.D., plenary speaker for the fifth annual Innovation and Commercialization Conference
Nancy T. Chang, Ph.D., founded Tanox, a biopharmaceutical company, in 1986 while on faculty at the Baylor College of Medicine. The company developed Xolair, an anti-inflammatory asthma treatment, that the U.S. Food and Drug Administration approved for use in 2003. Tanox was acquired by Genentech in 2007 for $919 million. Chang will speak during the… Read more »
5th annual Innovation and Commercialization Conference goes virtual
The Indiana University Office of Innovation and Commercialization will host the fifth annual Innovation and Commercialization Conference on Sept. 17 and 18 on Zoom. It is co-sponsored by the Office of the Vice President for Research, the Office of the Vice President for Government Relations and Economic Engagement, the Office of Business Partnerships, and the… Read more »
IU ICO Perspectives: a process to closely align with faculty
By Simran Trana, associate vice president, IU Innovation and Commercialization Office Over the six months that I have been at Indiana University, IU ICO has been reviewing its processes, practices and development programs that will align us more closely with faculty and what they need in terms of commercializing their intellectual property. Our commercialization managers… Read more »
IU Bloomington researchers disclose 42 inventions in 2019-20 fiscal year
Faculty, staff and student researchers at Indiana University Bloomington disclosed 42 inventions to the IU Innovation and Commercialization Office during the fiscal year July 1, 2019, to June 30, 2020. The IU Innovation and Commercialization Office’s mission is to drive innovation to the market for the benefit of the public, the university and the innovators… Read more »
IU researchers create multiple inventions, innovations in response to COVID-19
Faculty and staff at all Indiana University campuses and academic centers immediately and expertly respond to challenges that impact the lives and livelihoods of people around the world. They are proving their mettle again, responding to the coronavirus/COVID-19 pandemic by disclosing their inventions to the IU Innovation and Commercialization Office. IU ICO officials had received… Read more »
IU Innovation and Commercialization Office supports you and your COVID-19 innovations
By Simran Trana, associate vice president, IU Innovation and Commercialization Office During the pandemic, researchers at all Indiana University campuses and academic centers have focused on creating innovations to help people respond to obstacles created by COVID-19 and the novel coronavirus. These innovations take the form of vaccines and therapies, diagnostics, health care equipment, and… Read more »
Patent issued to IU innovation that could innovate therapeutics for cancer, Type 2 diabetes, other diseases
The U.S. Patent and Trademark Office has issued a patent on an innovation to improve upon therapeutics that pertain to controlling protein function. More than two dozen inhibitors of disease-associated enzymes have been developed and approved for clinical use. They are considered invaluable in illuminating the mechanism of these diseases and providing novel therapeutics. But… Read more »